Back to Results
First PageMeta Content
Clinical trial / Design of experiments / Pharmaceutical industry / Pharmacology / Brain tumor / Breast cancer / Chemotherapy / Radiation therapy / Medicine / Ribbon symbolism / Cancer treatments


PBTC[removed]A SUMMARY FOR PATIENTS AND FAMILIES Title: PBTC-042- A Phase 1 Study of CDK 4-6 inhibitor PD[removed]in children with recurrent, progressive, or refractory central nervous system tumors. This is a brief summar
Add to Reading List

Document Date: 2014-09-05 17:20:54

Open Document

File Size: 160,99 KB

Share Result on Facebook

Country

United States / United Kingdom / /

/

Facility

Preston Robert Tisch Brain Tumor Center Duke University Medical Center / /

IndustryTerm

care for your cancer / food / /

MedicalCondition

tumor / cancer / low grade gliomas / nausea / fatigue / form cancer / diarrhea / infection / refractory central nervous system tumors / brain tumor / anemia / childhood brain tumors / primary tumor / /

MedicalTreatment

chemotherapy / radiotherapy / /

Organization

National Cancer Institute / National Cancer Institute’s Cancer Information Service / PBTC / FDA / Preston Robert Tisch Brain Tumor Center Duke University Medical Center Durham / /

/

Product

Decadron / dexamethasone / PD-0332991 / /

ProvinceOrState

North Carolina / /

Technology

genomics / Pharmacokinetics / Pharmacogenetics / chemotherapy / MRI / /

URL

www.Cancer.gov / www.cancernet.org / www.cancer.gov/clinicaltrials / /

SocialTag